Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 4, 2009, Pages 1264-1266

  Peng, Sheng Ming ^a   Zou, Xiao Qing ^a   Ding, Hua Lan ^a   Ding, Yong Lan ^a   Lin, Yuan Bin ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Alkyl nitrate; Angiogenesis; Chrysin derivatives; Couple; Furazan derivatives

Indexed keywords

ANGIOGENIC FACTOR; CHRYSIN; CHRYSIN DERIVATIVE; FLAVONE DERIVATIVE; FURAZAN DERIVATIVE; NITRIC ACID DERIVATIVE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; NITRATES; NITRIC OXIDE DONORS; OXADIAZOLES; UMBILICAL VEINS;

EID: 59649121769     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.12.116     Document Type: Article

References (24)

1. Brownlee M. Nature 414 (2001) 813
2. Van der Zee R., Murohara T., Luo Z., Zollmann F., Passeri J., Lekutat C., and Isner J.M. Circulation 95 (1997) 1030
3. Hood J.D., Meininger C.J., Ziche M., and Granger H.J. Am. J. Physiol. 274 (1998) H1054
4. Wei L. J. Grad. Sun YAT-SEN Univ. (Nat. Sci. Med.) 4 (2007) 17
5. Ceriello A., Motz E., and Giugliano D. Lancet 355 (2000) 1272
6. Beckman J.A., Goldfine A.B., and Gordon M.B. Circulation 103 (2001) 1618
7. Sánchez I., Gómez-Garibay F., Taboada J., and Ruíz B.H. Phytother. Res. 14 (2000) 89
8. Bae E.A., Han M.J., Lee M., and Kim D.H. Biol. Pharm. Bull. 23 (2000) 1122
9. Han C. Cancer Lett. 114 (1997) 153
10. Birt D.F., Hendrich S., and Wang W. Pharmacol. Ther. 90 (2001) 157
11. Xu H.X., and Lee S.F. Phytother. Res. 15 (2001) 39
12. Hamiltonmiller J.M.T. Antimicrob. Agent Chemother. 39 (1995) 2375
13. Shivji G.M., Zielinska E., Kondo S., Mukhtar H., and Sander D.N. J. Invest. Dermatol. 106 (1996) 787
14. Matsuo N., Yamada K., Yamashita K., Shoji K., Mori M., and Sugano M. In Vitro Cell. Dev. Biol. 32 (1996) 340
15. Jain A., Martin M.C., Parveen N., Khan N.U., Parish J.H., and Hadi S.M. Phytother. Res. 13 (1999) 609
16. Pérez-Vizcaíno F., Ibarra M., Cogolludo A.L., Duarte J., Zaragozá-Arnáez F., Moreno L., López-López G., and Tamargo J. J. Pharmacol. Exp. Ther. 301 (2002) 66
17. Yamada J., and Tomita Y. Biosci. Biotechnol. Biochem. 58 (1994) 2197
18. Wolfman C., Viola H., Paladini A., Dajas F., and Medina J.H. Pharmacol. Biochem. Behav. 47 (1994) 1
19. Grassmann J., Hippeli S., and Elstner E.F. Plant Physiol. Biochem. 40 (2002) 471
20. Miura S., Watanabe J., Sano M., Tomita T., Osawa T., Hara Y., and Tomita I. Biol. Pharm. Bull. 18 (1995) 1
21. Shin J.S., Kim K.S., Kim M.B., Jeong J.H., and Kim B.K. Bioorg. Med. Chem. Lett. 9 (1999) 869
22. Gasco A.M., Fruttero R., Sorba G., and Gasco A. Liebigs Ann. Chem. (1991) 1211
23. 3, ppm) δ 12.77 (s, 1H), 7.89-7.87 (m, 2H), 7.66-7.64 (m, 2H), 7.57-7.49 (m, 6H), 6.69 (s, 1H), 6.48-6.47 (d, J = 2.0 Hz, 1H), 6.34-6.33 (d, J = 2.0 Hz, 1H), 5.32 (s, 2H), 4.77 (s, 2H); MS (EI) m/z: 486.
24. Jiang D.J., Jia S.J., Dai Z., and Li Y.J. J. Mol. Cell. Cardiol. 40 (2006) 529